Executive-only • Curated admission • Limited seats | Dates: 09–11 June 2027 | Venue: Barcelona, Spain
Strategic collaboration • Executive visibility • High-trust engagement

EICBPI 2027 Partners

EICBPI 2027 welcomes strategic partners aligned with biotechnology, pharmaceutical innovation, translational science, therapeutic development, drug delivery, manufacturing excellence, and cross-sector collaboration.

Audience quality
Executive-first

Curated biopharma decision-makers, innovation leads, and selected senior experts.

Partnership value
Visibility + outcomes

Meaningful access to leaders, partnerships, and strategic translational conversations.

Why partner with EICBPI?

Partnering with EICBPI positions your organisation alongside executive-level dialogue on biotechnology innovation, pharmaceutical development, translational strategy, and industry adoption.

Strategic
Visibility
Brand presence across priority touchpoints
Program, website, networking and curated introductions
Engagement
Access to senior delegates and invited leaders
High-relevance conversations over mass exposure
Positioning
Association with innovation and translational pathways
Biotech, pharma and industry leadership
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Strategic partnership pathways
Visibility • introductions • executive relevance
Partnership focus
Built for selective, high-value collaborations rather than broad promotional placement.
Start a Conversation →
Brand positioning
Executive-level visibility
Networking
Curated introductions
Themes
Biotech + pharma innovation
Support
Tailored collaboration scope

Who we work well with

We welcome collaborations with organisations that bring real relevance to the congress themes and contribute value to executive participants.

Industry partners

Biotechnology companies, pharmaceutical firms, therapeutic developers, CDMOs, CROs, and innovation-led life sciences organisations.

Technology & solution providers

Platforms, diagnostics, drug delivery technologies, manufacturing systems, analytics, automation, and digital health solution providers.

Research & innovation ecosystems

Research institutes, translational centres, biotech clusters, incubators, accelerators, and collaborative innovation networks.

Strategic institutions

Investment stakeholders, regulatory-aligned organisations, healthcare ecosystems, standards bodies, and policy-linked institutions.

What partnership can include

Collaboration models can be tailored depending on alignment, scale, and event objectives.

Strategic visibility

Website listing, selected acknowledgements, curated visibility in event communication materials, and branded presence where relevant.

Thought leadership alignment

Support for roundtables, strategic session participation, or aligned discussion formats where approved by the organising team.

Curated networking support

Selective introductions or partner-facing engagement opportunities based on mutual relevance and executive fit.

Custom collaboration opportunities

Tailored options may be considered for strategic institutions, corporate innovation groups, biotech ecosystems, and life sciences partners.

Our partnership approach

01
Relevance first

We prioritise alignment over volume.

02
Executive fit

Every collaboration should support the delegate experience.

03
Outcome orientation

We favour practical value over generic exposure.

Current / supporting partner display

You can replace the placeholders below with approved partner or collaborating organisation logos.

Request inclusion →
Partner Logo
Partner Logo
Partner Logo
Partner Logo